Recent Updates
Recently added Catalysts
STSS

Sharps Technology Announces $100 Million Stock Repurchase Program

Key Takeaway: Technology Announces $100 Million Stock Repurchase Program YORK, Oct. 2, 2025 /PRNewswire/ - Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ: STSS) today announced a stock repurchase program to acquire up to $100 million of the company's outstanding common stock. This

Full Press Release Details

Technology Announces $100 Million Stock Repurchase Program
YORK, Oct. 2, 2025 /PRNewswire/ - Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ: STSS)
today announced a stock repurchase program to acquire up to $100 million of the company's outstanding common stock. This new stock
repurchase program will enable the company to repurchase its shares in the open market and in negotiated transactions.
previously announced its plans to establish a Solanadigital asset treasury strategy and has acquired over 2 million
press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of
1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release
other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution
of its Solanadigital asset treasury strategy, and the potential opportunities such initiatives may create for retail and institutional
audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties
that could cause actual results to differ materially.
announcement contains forward-looking statements regarding Sharps Technology's stock buyback program. These statements reflect
the company's current expectations and are subject to risks and uncertainties. The buyback program is intended to enhance shareholder
value and demonstrates confidence in the company's long-term growth prospects. However, the timing, amount, and method of repurchasing
shares will depend on market conditions, regulatory requirements, and other factors. There is no guarantee that the program will be completed
as planned. These forward-looking statements are made in good faith and based on reasonable assumptions but are not guarantees of future
risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility
in the market price of SOL and other digital assets; changes in the regulatory or legal environment; competitive pressures; and general
market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's
filings with the Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at www.sec.gov.
statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements,
whether as a result of new information, future developments, or otherwise, except as required by law.
Technology is a medical device sales and distribution company that has adopted a digital asset treasury strategy focused on accumulating
SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the
Partners for Sharps Technology
Last updated: Oct 2, 2025